🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2028

Annual patent cliff calendar for 2028 — US pharmaceutical patents by expiration date.

Patents
603

Quick answer

603 indexed pharmaceutical patents have expiration dates in 2028. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7384909

    Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7384623

    High energy phototherapeutic agents

    Provectus Pharmatech, Inc. · Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7384978

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7384921

    Polymorphic forms of 6-11 bicyclic ketolide derivatives

    Enanta Pharmaceuticals, Inc. · Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7388079

    Delivery of pharmaceutical agents via the human insulin receptor

    The Regents of the University of California · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7388088

    High affinity human antibodies to tumor antigens

    The Regents of the University of California · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7387792

    Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration

    Collegium Pharmaceutical, Inc. · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7388074

    Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7388017

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7388002

    Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

    BioCryst Pharmaceuticals, Inc. · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7387881

    Detection and treatment of cancers of the liver

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7388032

    Sustained release compositions, process for producing the same and utilization thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7388071

    Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response

    The Regents of the University of California · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7387896

    MicroRNA vectors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7388089

    Anti-arthropod vector vaccines method of selecting and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7390807

    Crystal forms of lamotrigine and processes for their preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7390625

    Apoptosis-associated protein and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7390646

    Bacterial vectors and methods of use thereof

    The Regents of the University of California · Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7390510

    Preparation of hypericin bonded with poly-N-vinylamides

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7390668

    Intracorporeal medicaments for photodynamic treatment of disease

    Provectus Pharmatech, Inc. · Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7390813

    Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7390815

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7390808

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7393842

    Pyrazole analogs acting on cannabinoid receptors

    UNIVERSITY OF CONNECTICUT · Granted Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7393544

    Dispersion for pulmonary delivery of a bioactive agent

    Nektar Therapeutics · Granted Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7393833

    Chimeric proteins with phosphatidylserine binding domains

    The Board of Regents of the University of Oklahoma · Granted Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7393994

    Transgenic mouse model for neurodegenerative diseases

    The Regents of the University of California · Granted Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7393855

    2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and pyrimidines as antiviral agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7396542

    Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7396682

    Method for cell adhesion and wound healing

    REGENBiotech, Inc. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7396918

    IGF-I fusion polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7396839

    Crystalline forms of gatifloxacin

    Teva Pharmaceuticals USA, Inc. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7396860

    Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7396841

    Injections

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7396927

    Process for preparation of rosuvastatin calcium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7396933

    Quinolinone-carboxamide compounds

    Theravance, Inc. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7396848

    Neurotrophin production/secretion promoting agent

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7396816

    Low-molecular weight peptides inhibiting ion channel activity

    Pharmadesign, Inc. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7396664

    VEGF-binding fusion proteins and nucleic acids encoding the same

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7399606

    Methods for identifying IκB Kinase (IKK) inhibitors

    The Regents of the University of California · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7399827

    Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7399485

    Rapidly Disintegrable solid preparation

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7399465

    Pharmaceutical compositions for treating arthritis and inflammatory disease

    The Regents of the University of California · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7399488

    Abuse-deterrent pharmaceutical compositions of opiods and other drugs

    Collegium Pharmaceutical, Inc. · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7399612

    VEGF-binding fusion proteins and nucleic acids encoding the same

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7399750

    Methods for cardiac gene transfer

    The Regents of the University of California · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7399862

    5-HT4 receptor agonist compounds

    Theravance, Inc. · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7399863

    Amino-substituted ethylamino β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2028?

603 published patents in our USPTO index have expiration dates falling in calendar year 2028.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.